17 March 2020 | 19:30 – 20:30

This webinar is part of the “Women’s Health Matters” Medical Educational programme which aims to inspire, update and support healthcare professionals with an interest in women’s health.

A letter of attendance for 1 hour of medical education will be available for attendees completing the webinar.

The webinar will provide an evidence-based update on:

How Mirena® (52mg levonorgestrel IUS) can support oestrogen replacement during perimenopause

  • Overview on Mirena® and the licensed indications that can support oestrogen replacement during perimenopause
  • Supporting your everyday clinical practice and patient through evidence and examples
  • Review of NICE guidance
Time Session
19:30 Welcome, introductions and overview
19:35 How Mirena (52mg levonorgestrel IUS) can support oestrogen replacement during perimenopause? ➢ Overview on Mirena and the licenced indications that can support during the perimenopause ➢ Supporting your everyday clinical practice and patient through evidence and examples ➢ Review of NICE guidance
20:10 Q&A ➢ Share experiences ➢ Share best practice
20:30 Close

Agenda